Chemical Compound
Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'a,10a)-; Ergocryptine, dihydro- (7CI,8CI); (5'a,10a)-9,10-Dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione; 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3',6',18-trione deriv.; Indolo[4,3-fg]quinoline, ergotaman-3',6',18-trione deriv.; 9,10-Dihydro-a-ergocryptine; 9,10-Dihydroergocryptine; 9,10-Dihydroergokryptine; Almirid; Dihydro-a-ergocriptine; Dihydro-a-ergocryptin; Dihydro-a-ergocryptine; Dihydroergocriptine; Dihydroergocryptine; a-Dihydroergokryptine
CAS Registry Number
25447-66-9
Primary record
Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'a,10a)-; Ergocryptine, dihydro- (7CI,8CI); (5'a,10a)-9,10-Dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione; 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3',6',18-trione deriv.; Indolo[4,3-fg]quinoline, ergotaman-3',6',18-trione deriv.; 9,10-Dihydro-a-ergocryptine; 9,10-Dihydroergocryptine; 9,10-Dihydroergokryptine; Almirid; Dihydro-a-ergocriptine; Dihydro-a-ergocryptin; Dihydro-a-ergocryptine; Dihydroergocriptine; Dihydroergocryptine; a-Dihydroergokryptine
- 库存
- 5,992 克
- 纯度
- 98.7 %
- CAS
- 25447-66-9
化合物标识与属性
- CAS
- 25447-66-9
- PubChem CID
- 114948
- SMILES
- CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@@H]4C[C@H]5[C@@H](CC6=CNC7=CC=CC5=C67)N(C4)C)O
- Canonical SMILES
- CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
名称与同义词
- Dihydroergocryptine
- Dihydroergokryptine
- Dihydro-alpha-ergocryptine
- Dihydroergocriptine
- Almirid
- Cripar
- alpha-Dihydroergocryptine
- Dihydro a-Ergocryptine
- Alpha-Dihydroergocriptine
- Ergocryptine, dihydro-
- dihydro-|A-ergocryptine
- Dihydroergocryptine Mesylate
- Dihydroergokryptine Mesylate
- 9,10-dihydro-alpha-ergocryptine
- RefChem:920213
- dihydro-.alpha.-ergocryptine
- Mesylate, Dihydroergocryptine
- Mesylate, Dihydroergokryptine
- 9,10-Dihydroergocryptine
- DTXSID5048689
- Dihydroergocryptine mesilate
- AC1L3G9B
- Dihydroergokryptine Monomesylate
- 67V3FSL2GL
- CHEMBL1743263
- DTXCID5028615
- Monomesylate, Dihydroergocryptine
- Monomesylate, Dihydroergokryptine
- UNII-202229IR8Y
- CHEBI:59919
- SCHEMBL233373
- EINECS 246-993-6
- Dihydroergocryptine Monomesylate
- 25447-66-9
- 202229IR8Y
- SCHEMBL29471346
- BDBM81453
- PBUNVLRHZGSROC-VTIMJTGVSA-N
- ZINC3929793
- Tox21_113078
- BDBM50390994
- CID114948
- EBC-27344
- PDSP2_001088
- Dihydro-.alpha.-ergocryptine mesilate
- Dihydro-.alpha.-ergocryptine mesylate
- C32-H43-N5-O5
- CAS_159729
- CID:114948
- DB11274
- J2.292F
- NSC_159729
- NCGC00183332-01
- Dihydroergocristine Mesilate EP Impurity H
- SID:134223316
- CAS-25447-66-9
- LS-186448
- LS-187074
- LS-187682
- FT-0666907
- NS00008222
- D07835
- 12'-Hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)-9,10alpha-dihydroergotaman-3',6',18-trione
- D025443
- EN300-27019944
- Q905717
- (10alphaH)-12'-hydroxy-5'alpha-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)-9,10-dihydroergotaman
- Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha,10alpha)-
- Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-5'alpha-isobutyl-2'-isopropyl
- (6aR,9R,10aR)-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'.alpha.,10.alpha.)-
- (2R,4R,7R)-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene-4-carboxamide
- (2R,4R,7R)-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide
- (6aR,9R,10aR)-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
- (6Ar,9R,10aR)-N-[(1S,2R,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- 12'-HYDROXY-2'-(1-METHYLETHYL)-5'.ALPHA.-(2-METHYLPROPYL)-9,10.ALPHA.-DIHYDROERGOTAMAN-3',6',18-TRIONE
- 12'-Hydroxy-5'alpha-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)-10alpha-9,10-dihydroergotaman
- 246-993-6
- 9,10alpha-Dihydro-12 -hydroxy-2 -(1-methylethyl)-5 alpha-(2-methylpropyl)ergotaman-3 ,6 ,18-trione
- 9,10alpha-Dihydro-12 -hydroxy-2 -isopropyl-5 alpha-(2-methylpropyl)ergotaman-3 ,6 ,18-trion
- 9,10alpha-Dihydro-12 -hydroxy-2 -isopropyl-5 alpha-(2-methylpropyl)ergotaman-3 ,6 ,18-trione
- 9,10alpha-Dihydro-12 -hydroxy-2 -isopropyl-5 alpha-isobutylergotaman-3 ,6 ,18-trione
- Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'a,10a)-; Ergocryptine, dihydro- (7CI,8CI); (5'a,10a)-9,10-Dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione; 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3',6',18-trione deriv.; Indolo[4,3-fg]quinoline, ergotaman-3',6',18-trione deriv.; 9,10-Dihydro-a-ergocryptine; 9,10-Dihydroergocryptine; 9,10-Dihydroergokryptine; Almirid; Dihydro-a-ergocriptine; Dihydro-a-ergocryptin; Dihydro-a-ergocryptine; Dihydroergocriptine; Dihydroergocryptine; a-Dihydroergokryptine
- N-(2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo(7.3.0.0^(2,6))dodecan-4-yl)-6-methyl-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),9,12,14-tetraene-4-carboxamide